Medical Affairs – UK Life Sciences Labour Market Trends, April 2024
With the slump in the pharmaceutical sector set to continue, the long-awaited reforms to the MHRA have yet to materialise. As a result, drug approval in the UK lags behind the EU, further depressing the sector. 2023 seems to be the low point in that there has been an uptick in Q1 so far, and if this continues, it will increase by 9.1% this year compared to last. The recovery has been in London specifically, with volumes up 26.1% on last year.